Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoflipid vs. Intralipid for Cholestasis Prevention in Neonates
NCT03387579Phase 3Completed
- Sponsor
- Indiana University
- Start
- Nov 2018
- Primary completion
- Mar 2021
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of SMOFlipid in cholestasis, sponsored by Indiana University. Started Nov 2018; status: completed.
02
Drugs
SMOFlipid
03
Conditions
cholestasis
Beyond the preview
Go deeper on NCT03387579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03387579.